GIC to invest US$85m in Bloomage BioTechnology
[SINGAPORE] Singapore sovereign wealth fund GIC will invest HK$659 million (S$119.34 million) in Bloomage BioTechnology Corp as it bets on China's leading medical cosmetic products and services firm.
The investment includes HK$465 million in convertible bonds and HK$194 million in new shares, the Hong Kong-listed company said in a statement.
GIC, which according to the Sovereign Wealth Fund Institute is the world's twelfth biggest sovereign wealth fund with assets estimated at S$344 billion, has said in the past it is keen on investing in technology companies in markets like China and India.
Barclays was the sole placing agent for the deal.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Putin plans to meet Xi in China days after his new term starts
Biden vetoes bid to repeal US labour board rule on contract, franchise workers
Economic leaders of South Korea, Japan, China say FX volatility is a risk
US automakers win extension on use of Chinese graphite in EV tax credits
US service sector contracts in April; price pressures up
Thaksin’s daughter calls central bank independence an ‘obstacle’